-
Loading metrics
The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
- Steven N. Steinway,
- Hien Dang,
- Hanning You,
- C. Bart Rountree,
- Wei Ding
x
- Published: May 22, 2015
- https://doi.org/10.1371/journal.pone.0128159